Last Updated 25 October 2021.
3 Vaccines Approved for Use in Japan
-
Takeda
TAK-919 (Moderna formulation)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
2 trials in 1 country
-
Pfizer/BioNTech
BNT162b2- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 103 countries
41 trials in 15 countries
-
Oxford/AstraZeneca
AZD1222- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 124 countries
46 trials in 13 countries
9 Vaccines in Clinical Trials in Japan
-
Medicago
Plant-based VLP- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
6 trials in 2 countries
-
Takeda
TAK-019 (Novavax formulation)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Shionogi
S-268019- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
AnGes
AG0301-COVID19- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
AnGes
AG0302-COVID19- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
6 trials in 1 country
-
Daiichi Sankyo Co Ltd
DS-5670a- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Elixirgen Therapeutics Inc
EXG-5003- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Takeda
TAK-919 (Moderna formulation)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
2 trials in 1 country
-
KM Biologics Co Ltd
KD-414- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country